Be part of the knowledge.™

Cardiology

2207

LikeLikedUnlike

Episodes 661-675 of 845

Opioids, Fish Oils and Hibernating Bears
Clinician's Roundtable
Opioids, Fish Oils and Hibernating Bears
- Matthew J. Sorrentino, MD, FACC, FASH
  Peer
- Paul Iaizzo, PhD
  Peer
Visualizing the Beating Heart
Clinician's Roundtable
Visualizing the Beating Heart
- Matthew J. Sorrentino, MD, FACC, FASH
  Peer
- Paul Iaizzo, PhD
  Peer
CVD Risk in Special Female Populations
Lipid Luminations
CVD Risk in Special Female Populations
- Larry Kaskel, MD
  Peer
- Robert Wild, MD, MPH, D.Phil.
  Peer
When Chronic Illness Shortens a Medical Career
Clinician's Roundtable
When Chronic Illness Shortens a Medical Career
- Maurice Pickard, MD
  Peer
- Robert Klitzman, MD
  Peer
Encouraging CPR Participation from Bystanders
Clinician's Roundtable
Encouraging CPR Participation from Bystanders
- Mark Nolan Hill, MD
  Peer
- Michael Sayre, MD
  Peer
New Recommendations for CPR Participation from Bystanders
Clinician's Roundtable
New Recommendations for CPR Participation from Bystanders
- Mark Nolan Hill, MD
  Peer
- Michael Sayre, MD
  Peer
advertisement
Debating the Impact of Assisted Ventilation in CPR
Clinician's Roundtable
Debating the Impact of Assisted Ventilation in CPR
- Mark Nolan Hill, MD
  Peer
- Michael Sayre, MD
  Peer
The COURAGE Trial: Unpopular to Some, Embraced by Many
Lipid Luminations
The COURAGE Trial: Unpopular to Some, Embraced by Many
- Larry Kaskel, MD
  Peer
- William Boden, MD, FACC, FAHA
  Peer
American College of Cardiology 2008 Conference
Clinician's Roundtable
American College of Cardiology 2008 Conference
- Paul Raeburn
  Peer
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
  Peer
Impacting Atherosclerosis
Lipid Luminations
Impacting Atherosclerosis
- Larry Kaskel, MD
  Peer
- Kevin Williams, MD
  Peer
The COURAGE Trial's Impact on Clinical Practice
Lipid Luminations
The COURAGE Trial's Impact on Clinical Practice
- Larry Kaskel, MD
  Peer
- Perry Weinstock, MD
  Peer
CVD Risk Factors and Cognitive Impairment
Lipid Luminations
CVD Risk Factors and Cognitive Impairment
- Larry Kaskel, MD
  Peer
- David T. Nash, MD
  Peer
advertisement
Emerging Biomarkers and New Drugs
Lipid Luminations
Emerging Biomarkers and New Drugs
- Larry Kaskel, MD
  Peer
- Michael H. Davidson, MD
  Peer
Noninvasive Imaging for the Vulnerable Patient
Clinician's Roundtable
Noninvasive Imaging for the Vulnerable Patient
- Larry Kaskel, MD
  Peer
- Matt Budoff, MD
  Peer
Misconceptions in Coronary Risk & Lipid Medicine
Lipid Luminations
Misconceptions in Coronary Risk & Lipid Medicine
- Larry Kaskel, MD
  Peer
- James Ehrlich, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended